Avadel Pharmaceuticals plcAvadel Pharmaceuticals plcAvadel Pharmaceuticals plc

Avadel Pharmaceuticals plc

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.11 B‬USD
−0.00USD
‪−48.83 M‬USD
‪169.12 M‬USD
‪90.95 M‬
Beta (1Y)
1.15
Employees (FY)
188
Change (1Y)
+34 +22.08%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About Avadel Pharmaceuticals plc


CEO
Gregory J. Divis
Website
Headquarters
Dublin
Founded
2015
IPO date
Jan 16, 1952
Identifiers
2
ISIN IE00BDGMC594
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.

Check out other big names from the same industry as AVDL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Avadel Pharmaceuticals plc stocks are traded under the ticker AVDL.
We've gathered analysts' opinions on Avadel Pharmaceuticals plc future price: according to them, AVDL price has a max estimate of 23.00 USD and a min estimate of 18.50 USD. Watch AVDL chart and read a more detailed Avadel Pharmaceuticals plc stock forecast: see what analysts think of Avadel Pharmaceuticals plc and suggest that you do with its stocks.
AVDL reached its all-time high on Nov 17, 2025 with the price of 23.51 USD, and its all-time low was 2.50 USD and was reached on May 31, 2022. View more price dynamics on AVDL chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Avadel Pharmaceuticals plc financials in yearly and quarterly reports right on TradingView.
Avadel Pharmaceuticals plc is going to release the next earnings report on Mar 9, 2026. Keep track of upcoming events with our Earnings Calendar.
Avadel Pharmaceuticals plc revenue for the last quarter amounts to ‪77.47 M‬ USD, despite the estimated figure of ‪73.58 M‬ USD. In the next quarter, revenue is expected to reach ‪79.99 M‬ USD.
AVDL net income for the last quarter is ‪20.00 K‬ USD, while the quarter before that showed ‪9.66 M‬ USD of net income which accounts for −99.79% change. Track more Avadel Pharmaceuticals plc financial stats to get the full picture.
No, AVDL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 13, 2026, the company has 188 employees. See our rating of the largest employees — is Avadel Pharmaceuticals plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Avadel Pharmaceuticals plc EBITDA is ‪8.20 M‬ USD, and current EBITDA margin is −23.49%. See more stats in Avadel Pharmaceuticals plc financial statements.
Like other stocks, AVDL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Avadel Pharmaceuticals plc stock right from TradingView charts — choose your broker and connect to your account.